Lapatinib Enhances Trastuzumab-Mediated Antibody-Dependent Cellular Cytotoxicity via Upregulation of HER2 in Malignant Mesothelioma Cells
Oncology Reports - Greece
doi 10.3892/or.2015.4314
Full Text
Open PDFAbstract
Available in full text
Date
September 28, 2015
Authors
Publisher
Spandidos Publications